{"name":"Gedeon Richter","slug":"gedeon-richter","ticker":"RICHTER.BD","exchange":"Budapest Stock Exchange","domain":"gedeonrichter.com","description":"Gedeon Richter was a Hungarian pharmacist, founder of Gedeon Richter plc and a pioneer of the modern Hungarian pharmaceutical industry.","hq":"Budapest, Hungary","founded":1844,"employees":"","ceo":"Gábor Orbán","sector":"Women's Health / CNS","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"0","metrics":{"revenue":2200000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Gynokadin patent cliff ($100.0M at risk)","drug":"Gynokadin","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Dydrogesterone patent cliff ($50.0M at risk)","drug":"Dydrogesterone","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Cariprazine PR tablet B","genericName":"Cariprazine PR tablet B","slug":"cariprazine-pr-tablet-b","indication":"Other","status":"phase_1"},{"name":"Cariprazine capsule","genericName":"Cariprazine capsule","slug":"cariprazine-capsule","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"RGB-14-P","genericName":"RGB-14-P","slug":"rgb-14-p","indication":"Treatment-resistant depression","status":"phase_3"}]}],"pipeline":[{"name":"Cariprazine PR tablet B","genericName":"Cariprazine PR tablet B","slug":"cariprazine-pr-tablet-b","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cariprazine capsule","genericName":"Cariprazine capsule","slug":"cariprazine-capsule","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"RGB-14-P","genericName":"RGB-14-P","slug":"rgb-14-p","phase":"phase_3","mechanism":"RGB-14-P is a small molecule that targets the serotonin receptor.","indications":["Treatment-resistant depression"],"catalyst":""}],"recentEvents":[{"date":"2022-09-01","type":"regulatory","headline":"Gedeon Richter Receives EU Approval for Contraceptive Pill","summary":"Gedeon Richter announced that it has received EU approval for its contraceptive pill, which is expected to launch in key European markets.","drugName":"Contraceptive Pill","sentiment":"positive"},{"date":"2021-02-10","type":"earnings","headline":"Gedeon Richter Reports Strong Q4 Earnings","summary":"Gedeon Richter reported strong Q4 earnings, driven by growth in its women's health and CNS franchises.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQbFZ5UXJXWWJoczlFS0xWMUo5SUt3V0JqWWpiM2NTSEhueFlwWTVmWk9mTVlFaUxPV0ptUU42elN2Nld2bUtrak0zS0c2c05rLUV0U3BBUXJuVXFTSlY4TkgzeFVNT2VMakV3NDR6TjNiWWF3ZEhEUFEtT3NNa2xOdjM3Z1IwblVjbHA0RDcwbFpwY1lPdGRpWnROcG05ZWNGMXRTZjk0ZEtmQ0tIN1kyUDQ4T0laSTdFYm5Ba1JCc2xWWDg?oc=5","date":"2026-04-03","type":"pipeline","source":"AD HOC NEWS","summary":"Richter Gedeon Nyrt. Stock: A Leading Hungarian Pharma Player with Strong R&D Focus for Global Inves - AD HOC NEWS","headline":"Richter Gedeon Nyrt. Stock: A Leading Hungarian Pharma Player with Strong R&D Focus for Global Inves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUnE3Z0xtaHQ3VnBhZF9oQk91dTNzb3lFd3FvYjBaV0RoTUxyb3pxR2JmblZTN1pENVZiSmZVSkNpWFJNaVB6bzFCRXBrRGUyNDMzSGM2VE54ZlQwMmg3NDkzeC1SMkJYNU5XOXJCUC0yS0VSYXMxWHN0d05la2NLOGc4Y3gtazdJSzA3RWtqMkotdXhxRE51RTBKODdOdE9HWVdOY2tudWp5Rl8xQ0dCNVZxWThnNV9mcXFvcUFJQQ?oc=5","date":"2026-02-27","type":"pipeline","source":"The Pharma Letter","summary":"Gedeon Richter posts strong year-end with adjusted EBIT exceeding expectations - The Pharma Letter","headline":"Gedeon Richter posts strong year-end with adjusted EBIT exceeding expectations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNdGlGbWlwZmY1d1BXSUZqYTlrM3R2c1RWeE9LaERsT0pXNXRBcXBLX0pCNDlHZjhQbzhmUlFZamJsbTBId3daWVhqNkJJY2c4Vy1WdjRKNE0zTGxDaXNwQ284RGo0NXpvT3d6RW5Hb2F3VWZKczk4aTJmamgyX3FWcXBLQjJZdEhJZF9rQ3NHaVpYVDlyenlEbFJjYlpsRldZbUtnUkozVzR3Rm80UXZubGtUVQ?oc=5","date":"2026-02-18","type":"deal","source":"Femtech Insider","summary":"FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider","headline":"FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOZ1FOTGhmMHVvaFdSZnJQSXVyS2pIWFNBMHpWUURhNjFZUUNQNVdoUzNyMVlISk1GLUVxU0kxbkJUQ3RVWkVvSmZPb0pZcHNSRFFPVmpwMkdnSkQ0RGhhd25nLXJGQ1poc2hvV3dvYW1sR2hMTnhaaXlFdFY2YlF5eFNjeHZ2dDEwMkk5U0E4ZzdqR3o1R0JVSmcwNi05QWZMcUpJYmgzYnVYZ2ZzWmNMV193MTU1VlBsQVZXQU9DMWRlN2lGbjA4?oc=5","date":"2026-02-17","type":"deal","source":"Pharmafile","summary":"Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals - Pharmafile","headline":"Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOdndaSkhEeG85WUdJeFoxVE51OU03aS0xdzMxendnWlhVMmZzWHo1SEtBN09zVTBVTHF3b1RfUVA2T00ySWZmRXFYb2MyRWdzQnczU21LbThTUWRocEFMbDFjZ1c5VmcxRl9XdUxTenZBLWp3TkhEOXdSUUF4bENaN3I3WmswWXZYcktKelpXMW9FREZGMk9lYkJlTF92cEU4dkJB?oc=5","date":"2026-02-04","type":"pipeline","source":"hungarytoday.hu","summary":"Innovative Cooperation between Gedeon Richter and Fuji Pharma To Be Expanded - hungarytoday.hu","headline":"Innovative Cooperation between Gedeon Richter and Fuji Pharma To Be Expanded","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQekZ0SjVuZGRESl83MDBXZHV0d1JGTVAtcVRGUlRncFlCNXBWVzFNSGZoZ0R1NER1dUpkVUN0eVNiMy1aMFQzS09ZalBFOTAtRl9MX3J2UzN6VW5VQU1FTlF2MFdHbzl3Ry0xMV9HbmdwREhmeVJicEVYNElKZWhUYWNHVzJkaFVtUGQw?oc=5","date":"2026-01-27","type":"pipeline","source":"pharmatimes.com","summary":"Gedeon Richter UK takes over UK rights to cariprazine - pharmatimes.com","headline":"Gedeon Richter UK takes over UK rights to cariprazine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOUFpKTC1pOS03YlJoNGZaRW50Z2tMTFlqS09ZUEY5c2FlZjlIR25lTFNMaERCc0UzSTg2RF9kSXRZQ3o4RWtLRDNWYmVrRU5vYmV5anhqajNpTUxjckRESDIybk9OdG8yNFgxY2s3aF9ZNk5FQURNLWx4UnZWWjc5NGlOMmZqMG1hYWNn?oc=5","date":"2025-09-30","type":"regulatory","source":"hungarytoday.hu","summary":"Pharma Giant Richter’s Shares Surge after U.S. Drug Approval - hungarytoday.hu","headline":"Pharma Giant Richter’s Shares Surge after U.S. Drug Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPakdvWE9KT3UzeW9TcGt5aGZHNjBHNFJzUE0wS0ltekc0NkVMUldFa0lkUS1XTWhRZk9vRmV4dmE1SVRpQmw0bk1zNnZNNDc5TXpQbklhM28wSlBkNnl0QmlOaFFUdnhWSEU0ZVBvWGEwT0hSXzItS0tpQ0c4a3NNS0YxTlpiRTNRYk9JbkNGX1d3bEo0ek5UZmRSQzdmWnhiTXdyR2NyeG1Pbm5vV0VucEhwLVR2TnVGNVlz?oc=5","date":"2025-08-06","type":"pipeline","source":"Investing.com","summary":"Gedeon Richter reports 8% pharma growth in first half 2025 - Investing.com","headline":"Gedeon Richter reports 8% pharma growth in first half 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxONU1ESlZ5dlFlQTA2MDdUNXhXVnM4eDQ3VFVyQVZ2aHphbW5xeXhUZmRXUHZGVjBwWWVxTEVmcmFhQ3NUUmp0dHN4TEJhb2I3S1kxVVh0cHpleWYxTWNVeTA3OVlDbUVUSDJGZHZjMmlZUmtOOXdZd0xlX2Jwd3B6VGl5VXVBQVQ3TDUwam9zVlN6ZkhRWWNTWmVtdWdsWEphM2t5NWJKc19YcHdXbGhubGc2NEY0dw?oc=5","date":"2024-10-25","type":"pipeline","source":"Fierce Biotech","summary":"AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator - Fierce Biotech","headline":"AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOYy1TUnFuOTkwLTZBLW40X0lTWFN2WnVNN1JyaExlNDA3YUVXSFFVT0NVVS1vMU1mZWM2bWJ2eG45VkZ0aGVJV1gtMDZXdzdLSm5VRlloVjdqczdvMFgwejc2UHNZRDJqS0dyeGZZd2w2WVFXRmc4b1hpZmdaX1JGRV9BMzdOX1RSZTZVQ3EyMGN5WkNMa3MwQlZzWDZFeGc?oc=5","date":"2024-09-15","type":"pipeline","source":"European Biotechnology Magazine","summary":"Richter-Helm Biologics triples production capacity - European Biotechnology Magazine","headline":"Richter-Helm Biologics triples production capacity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQdUtjLWxSaGZaMjRpM3Y2enZkNjRNR1k2SDFvT2ZuRk4wU21LTmNKSnExN2RqMElYQVBXZTVvSHg4dVNEbXNNQTFxeEtZTW9UelFxeVdiTVRnZjZpRmpMMGFtX0hQbDdxWFcwYXFzQzNwalJ1d0w1eXVxYzN4S2hnU2hqTC01RjBuSFJzaTRSQWJYQi1jbmo1bnRnNHljNDVUQzVSa2MydzN4TEMxOWxmdmI4V0FnbjZmemgtMXRTZUI2Mi1ld2c?oc=5","date":"2024-04-08","type":"pipeline","source":"hungarianconservative.com","summary":"Hungarian Richter Increases R&D Budget by Nearly 30 Million Euros in 2024 - hungarianconservative.com","headline":"Hungarian Richter Increases R&D Budget by Nearly 30 Million Euros in 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQNktwZWJjN0pjejJBVnROSzBGc0FqRFRmZ2RSaTFfVEJSVGx4QlN6ZS12X2F6NVJhSk5pUlIxT19FYzZfeUlGWmU5bHNGQnFqRlpHbEFiWEEteVloc0tRLXJlUTNxa3B5X2RKTnNSanlRVW01Q2VEbEtweU5xZ3JIa1lVcmtDcWtZZFozSzU3M0pUV2M3Z0stX1hiMWpXa3o5bDBvc2wzTFdET0d6REMxRDNQV0I?oc=5","date":"2022-03-11","type":"deal","source":"Contract Pharma","summary":"AbbVie and Gedeon Richter Enter Co-Development and License Agreement - Contract Pharma","headline":"AbbVie and Gedeon Richter Enter Co-Development and License Agreement","sentiment":"neutral"}],"patents":[{"drugName":"Gynokadin","drugSlug":"estradiol","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Dydrogesterone","drugSlug":"dydrogesterone","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"EU","annualRevenue":50000000}],"drugCount":3,"phaseCounts":{"phase_1":2,"phase_3":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Merck","Pfizer","Novartis"],"therapeuticFocus":["Women's Health","Central Nervous System Disorders"],"financials":null,"yahoo":null}